- conflicts or gaps
- [[{"field": {"value": "founders", "source_urls": ["https://www.ycombinator.com/companies/helix-nanotechnologies", "https://craft.co/helixnano", "https://www.linkedin.com/in/carinamn"]}, "issue": {"value": "YC profile lists only Nikolai Eroshenko as founder; Craft/LinkedIn/Crunchbase list Hannu Rajaniemi + Nikolai Eroshenko; Pharmaletter and Carina Namih sources list Carina Namih as co-founder with Hannu Rajaniemi", "source_urls": ["https://www.ycombinator.com/companies/helix-nanotechnologies", "https://www.thepharmaletter.com/helix-nanotechnologies", "https://www.linkedin.com/in/carinamn"]}}, {"field": {"value": "total_funding", "source_urls": ["https://craft.co/helixnano", "https://www.cbinsights.com/company/helix-nanotechnologies/financials", "https://www.linkedin.com/company/helixnano"]}, "issue": {"value": "Total funding ranges from $6.4M (Craft) to $59.2M (LinkedIn); CB Insights shows $250K (likely incomplete/paywalled); no authoritative single public figure", "source_urls": ["https://craft.co/helixnano", "https://www.cbinsights.com/company/helix-nanotechnologies/financials", "https://www.linkedin.com/company/helixnano", "https://www.premieralts.com/companies/helixnano/investor-list"]}}, {"field": {"value": "employees", "source_urls": ["https://www.linkedin.com/company/helixnano", "https://www.ycombinator.com/companies/helix-nanotechnologies"]}, "issue": {"value": "Headcount varies 10–22 across YC, YCDB, LinkedIn, GetLatka; LinkedIn shows ~37% YoY decline to 13 employees", "source_urls": ["https://www.linkedin.com/company/helixnano", "https://www.ycombinator.com/companies/helix-nanotechnologies", "https://getlatka.com/companies/helixnano.com"]}}, {"field": {"value": "executive_titles", "source_urls": ["https://craft.co/helixnano", "https://www.linkedin.com/company/helixnano"]}, "issue": {"value": "Nikolai Eroshenko listed as CSO on YC/Craft; LinkedIn lists Marianna Keaveney as Chief Scientific Officer", "source_urls": ["https://craft.co/helixnano", "https://www.linkedin.com/company/helixnano"]}}, {"field": {"value": "location", "source_urls": ["https://www.ycombinator.com/companies/helix-nanotechnologies", "https://craft.co/helixnano"]}, "issue": {"value": "YC lists Boston; Craft lists Cambridge, MA with street address; press releases use Boston, MA", "source_urls": ["https://www.ycombinator.com/companies/helix-nanotechnologies", "https://craft.co/helixnano", "https://www.einpresswire.com/article/697341469/helixnano-s-subsidiary-helixnano-australia-receives-hrec-approval-to-initiate-a-phase-1-clinical-trial"]}}, {"field": {"value": "company_description", "source_urls": ["https://www.ycombinator.com/companies/helix-nanotechnologies", "https://www.ycdb.co/company/helix-nanotechnologies", "https://www.vcbacked.co/company/helixnano"]}, "issue": {"value": "Positioning varies: mRNA platform (YC), AI for genetic disease (YCDB/VCBacked), cancer-focused (Craft)", "source_urls": ["https://www.ycombinator.com/companies/helix-nanotechnologies", "https://www.ycdb.co/company/helix-nanotechnologies", "https://craft.co/helixnano"]}}, {"field": {"value": "website_content", "source_urls": ["https://helixnano.com"]}, "issue": {"value": "Public website is minimal teaser ('More soon') with no product, team, or pipeline detail", "source_urls": ["https://helixnano.com"]}}, {"field": {"value": "clinical_trial_status", "source_urls": ["https://sigma.larvol.com/company.php?e1=847077&sourcepg=TZC&tab=OTTtrac", "https://www.thepharmaletter.com/helix-nanotechnologies"]}, "issue": {"value": "HN-0001 Phase 1 cohort 3 trial withdrawn (ACTRN12624000719538) while main trial still recruiting; limited public efficacy data", "source_urls": ["https://sigma.larvol.com/company.php?e1=847077&sourcepg=TZC&tab=OTTtrac", "https://www.thepharmaletter.com/helix-nanotechnologies"]}}, {"field": {"value": "medicus_partnership", "source_urls": ["https://medicuspharma.com/medicus-pharma-ltd-announces-a-memorandum-of-understanding-mou-with-helix-nanotechnologies-inc-to-develop-thermostable-infectious-disease-vaccines/", "https://finance.yahoo.com/sectors/healthcare/articles/medicus-pharma-reports-first-quarter-203000912.html"]}, "issue": {"value": "Medicus MOU is non-binding; no assurance definitive JV or commercial agreement will be executed as of Q1 2026", "source_urls": ["https://finance.yahoo.com/sectors/healthcare/articles/medicus-pharma-reports-first-quarter-203000912.html", "https://medicuspharma.com/medicus-pharma-ltd-announces-a-memorandum-of-understanding-mou-with-helix-nanotechnologies-inc-to-develop-thermostable-infectious-disease-vaccines/"]}}]]
- source urls
- ["https://craft.co/helixnano", "https://finance.yahoo.com/sectors/healthcare/articles/medicus-pharma-reports-first-quarter-203000912.html", "https://getlatka.com/companies/helixnano.com", "https://helixnano.com", "https://medicuspharma.com/medicus-pharma-ltd-announces-a-memorandum-of-understanding-mou-with-helix-nanotechnologies-inc-to-develop-thermostable-infectious-disease-vaccines/", "https://redqueen.bio/", "https://sifted.eu/articles/carina-namih-plural-helixnano-interview", "https://sigma.larvol.com/company.php?e1=847077&sourcepg=TZC&tab=OTTtrac", "https://www.cbinsights.com/company/helix-nanotechnologies/financials", "https://www.crunchbase.com/organization/helixnano", "https://www.einpresswire.com/article/697341469/helixnano-s-subsidiary-helixnano-australia-receives-hrec-approval-to-initiate-a-phase-1-clinical-trial", "https://www.helixnano.com/careers/clinical-product-manufacturing-lead", "https://www.ianhogarth.com/blog/2023/3/23/mrna-pioneer-and-founder-turned-investor-carina-namih-joins-plural", "https://www.linkedin.com/company/helixnano", "https://www.linkedin.com/in/carinamn", "https://www.linkedin.com/in/hannur", "https://www.longtermwiki.com/wiki/E556", "https://www.pluralplatform.com/team/carina-namih", "https://www.premieralts.com/companies/helixnano/investor-list", "https://www.reuters.com/technology/openai-backs-startup-aiming-block-ai-enabled-bioweapons-2025-11-13/", "https://www.sec.gov/Archives/edgar/data/1997296/000106299325013468/exhibit99-1.htm", "https://www.theinstitute.com/fellow/hannu-rajaniemi", "https://www.thepharmaletter.com/helix-nanotechnologies", "https://www.vcbacked.co/company/helixnano", "https://www.ycdb.co/company/helix-nanotechnologies", "https://www.ycombinator.com/companies/helix-nanotechnologies"]